Applications of transrectal ultrasound in prostate cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Transrectal ultrasound (TRUS) was first developed in the 1970s. TRUS-guided biopsy, under local anaesthetic and prophylactic antibiotics, is now the most widely accepted method to diagnose prostate cancer. However, the sensitivity and specificity of greyscale TRUS in the detection of prostate cancer is low. Prostate cancer most commonly appears as a hypoechoic focal lesion in the peripheral zone on TRUS but the appearances are variable with considerable overlap with benign lesions. Because of the low accuracy of greyscale TRUS, TRUS-guided biopsies have become established in the acquisition of systematic biopsies from standard locations. The number of systematic biopsies has increased over the years, with 10–12 cores currently accepted as the minimum standard. This article describes the technique of TRUS and biopsy and its complications. Novel modalities including contrast-enhanced modes and elastography as well as fusion techniques for increasing the sensitivity of TRUS-guided prostate-targeted biopsies are discussed along with their role in the diagnosis and management of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Wei, K., Jayaweera, A. R., Firoozan, S., Linka, A., Skyba, D. M., & Kaul, S. (1998) · Circulation · doi:10.1161/01.cir.97.5.473 · Cited by 1,616 · cited 1×
“Intermittent high-power ultrasound pulses may be used to destroy microbubbles within a beam, and the rate of replenishment in the field can be used to calculate microbubble flow rate, a surrogate of perfusion and fractional vascular volume [51].”
MethodRandom Systematic Versus Directed Ultrasound Guided Transrectal Core Biopsies of the Prostate
Hodge, K. K., McNeal, J. E., Terris, M. K., & Stamey, T. A. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)38664-0 · Cited by 1,571 · cited 1×
“The number of biopsies has increased since the original sextant biopsy developed by Hodge et al [30].”
BackgroundPiscaglia, F., Nolsøe, C., Dietrich, C., Cosgrove, D., Gilja, O., Bachmann Nielsen, M., Albrecht, T., Barozzi, L., Bertolotto, M., Catalano, O., et al. (2011) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0031-1281676 · Cited by 1,082
Heidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Matveev, V. B., Mottet, N., Wiegel, T., & Zattoni, F. (2013) · Cited by 875
Complications After Prostate Biopsy: Data From SEER-Medicare
Loeb, S., Carter, H. B., Berndt, S. I., Ricker, W., & Schaeffer, E. M. (2011) · Journal of Urology · doi:10.1016/j.juro.2011.06.057 · Cited by 685
Eichler, K., Hempel, S., Wilby, J., Myers, L., Bachmann, L. M., & Kleijnen, J. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00957-2 · Cited by 518 · cited 1×
“Eichler et al [33] analysed 87 studies (20 698 patients) and concluded that schemes of 12 cores that included posterior/laterally directed cores struck a balance between detection rate and adverse events.”
BackgroundPinto, P. A., Chung, P. H., Rastinehad, A. R., Baccala, A. A., Kruecker, J., Benjamin, C. J., Xu, S., Yan, P., Kadoury, S., Chua, C., et al. (2011) · Journal of Urology · doi:10.1016/j.juro.2011.05.078 · Cited by 450 · cited 1×
“Recently, a new technique has emerged which allows a preperformed MRI to be coregistered to landmarks so that real-time virtual ultrasound-guided biopsied can be performed [75–78].”
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials
Djulbegovic, M., Beyth, R. J., Neuberger, M. M., Stoffs, T. L., Vieweg, J., Djulbegovic, B., & Dahm, P. (2010) · BMJ · doi:10.1136/bmj.c4543 · Cited by 337 · cited 1×
“Two recent reviews of several randomised controlled trials concluded that there was insufficient evidence to support the use of PSA testing to screen for prostate cancer and its use may potentially cause harm [10, 11].”
BackgroundComparison of microscopic vascularity in benign and malignant prostate tissue
Bigler, S. A., Deering, R. E., & Brawer, M. K. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90304-y · Cited by 323 · cited 1×
“Pathological analysis of prostate tumours demonstrates increased microvessel density compared with the surrounding normal parenchyma [43].”
BackgroundReal-time MRI-TRUS fusion for guidance of targeted prostate biopsies
Xu, S., Kruecker, J., Turkbey, B., Glossop, N., Singh, A. K., Choyke, P., Pinto, P., & Wood, B. J. (2008) · Computer Aided Surgery · doi:10.3109/10929080802364645 · Cited by 295 · cited 1×
“The technique allows multiplanar biopsy planning, and Xu et al [77] showed an accuracy of 2.”
MethodAge and Racial Distribution of Prostatic Intraepithelial Neoplasia
Sakr, W., Grignon, D. J., Haas, G. P., Heilbrun, L. K., Pontes, J. E., & Crissmana, J. D. (1996) · European Urology · doi:10.1159/000474163 · Cited by 295 · cited 1×
“It has been estimated from post-mortem data that approximately half of all males in their fifties have prostate cancer, which increases to 80% by the age of 80 years, but only 1 in 26 men will die from their disease—supporting the fact that males are more likely to die with prostate cancer than from it [5, 6].”
BackgroundRosario, D. J., Lane, J. A., Metcalfe, C., Donovan, J., Doble, A., Goodwin, L., Davis, M., Catto, J. W. F., AVERY, K. N. L., Neal, D. E., et al. (2012) · BMJ · doi:10.1136/bmj.d7894 · Cited by 294
Cancer Incidence and Mortality
Ramirez, A. G., Thompson, I. M., & Vela, L. (2013) · The South Texas Health Status Review · doi:10.1007/978-3-319-00233-0_5 · Cited by 213
Harvey, C., Pilcher, J. M., Eckersley, R. J., Blomley, M. J. K., & Cosgrove, D. O. (2002) · Clinical Radiology · doi:10.1053/crad.2001.0918 · Cited by 203 · cited 1×
“Microbubble-specific techniques allow imaging of vessels down to 50–100 mm in diameter [46, 47].”
MethodSelf-citationFrauscher, F., Klauser, A. S., Volgger, H., Halpern, E. J., Pallwein, L., Steiner, H., Schuster, A. H., Horninger, W., Rogatsch, H., & Bartsch, G. C. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65171-3 · Cited by 192
Self-citationProstate Cancer: Contrast-enhanced US for Detection
Halpern, E. J., Rosenberg, M., & Gomella, L. G. (2001) · Radiology · doi:10.1148/radiology.219.1.r01ap21219 · Cited by 183 · cited 1×
“Halpern et al [52], using contrast-enhanced real-time and intermittent harmonic imaging in addition to power Doppler, showed a significant increase in sensitivity from 38% to 65% while specificity was maintained at 80% in cancer detection.”
Screening for prostate cancer: an updated Cochrane systematic review
Ilic, D., O’Connor, D., Green, S., & Wilt, T. J. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.10032.x · Cited by 176 · cited 1×
“Two recent reviews of several randomised controlled trials concluded that there was insufficient evidence to support the use of PSA testing to screen for prostate cancer and its use may potentially cause harm [10, 11].”
BackgroundHadaschik, B. A., Kuru, T. H., Tulea, C., Rieker, P., Popeneciu, I. V., Simpfendörfer, T., Huber, J., Zogal, P., Teber, D., Pahernik, S., et al. (2011) · Journal of Urology · doi:10.1016/j.juro.2011.07.102 · Cited by 176 · cited 2×
“Hadaschik et al [78] in a study of 106 males demonstrated that, in highly suspicious MR lesions, the perineal biopsy detection rate was 95.8% with a significantly higher positivity rate than non-targeted cores.”
BackgroundInfluentialUltrasound Molecular Imaging of VEGFR2 in a Rat Prostate Tumor Model Using BR55
Tardy, I., Pochon, S., Théraulaz, M., Emmel, P., Passantino, L., Tranquart, F., & Schneider, M. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181ee8b83 · Cited by 133 · cited 1×
“In a study comparing BR55 (a new antivascular endothelial growth factor receptor 2-specific bubble) and nonlabelled SonovueH (Bracco, Milan, Italy) in rat prostate cancer, both bubbles provided information in the early vascular phase, but BR55 had a late-phase binding to tumour endothelium allowing an extended window…”
BackgroundWink, M. H., Frauscher, F., Cosgrove, D. O., Chapelon, J., Palwein, L., Mitterberger, M., Harvey, C., Rouvière, O., de la Rosette, J. J. M. C. H., & Wijkstra, H. (2008) · European Urology · doi:10.1016/j.eururo.2008.06.057 · Cited by 132 · cited 1×
“Overall contrast-enhanced ultrasound targeted biopsies improve the sensitivity of the detection of prostate cancer despite a lack of specificity, but not sufficiently to avoid systematic biopsies; therefore, the place of contrastenhanced ultrasound is still under debate [58, 67–70].”
BackgroundSelf-citationPallwein, L., Mitterberger, M., Struve, P., Horninger, W., Aigner, F., Bartsch, G. C., Gradl, J., Schurich, M., Pedross, F., & Frauscher, F. (2007) · European Radiology · doi:10.1007/s00330-007-0606-1 · Cited by 124 · cited 1×
“Pallwein et al [72], in a study of 230 patients using two independent examiners, performed elastography-directed targeted biopsies followed by 10 systematic biopsies.”
BackgroundSelf-citationAigner, F., Pallwein, L., Junker, D., Schäfer, G., Mikuz, G., Pedross, F., Mitterberger, M. J., Jaschke, W. R., Halpern, E. J., & Frauscher, F. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.05.026 · Cited by 122
Self-citationCosgrove, D., Eckersley, R. J., Blomley, M. J. K., et al. (2001) · European Radiology · doi:10.1007/s003300100985 · Cited by 101 · cited 1×
“curves may be generated (Figure 13) from which many functional indices [47–50] can be derived, including bolus arrival time, time to peak intensity, area under the curve and washin/washout curves as well as more complex indices.”
BackgroundAigner, F., Pallwein, L., Mitterberger, M., Pinggera, G., Mikuz, G., Horninger, W., & Frauscher, F. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08038.x · Cited by 90 · cited 1×
“Aigner et al [58] compared contrast-enhanced ultrasound targeted biopsies with 10-core systematic biopsies in 44 patients.”
BackgroundSelf-citationBiopsy standards for detection of prostate cancer
Djavan, B., & Margreiter, M. (2007) · World Journal of Urology · doi:10.1007/s00345-007-0151-1 · Cited by 85 · cited 1×
“This is reflected in large variations in cancer detection between centres and also in the fact that increasing the number of cores will increase both cancer detection and complication rates [32].”
BackgroundDirected Biopsy During Contrast-Enhanced Sonography of the Prostate
Halpern, E. J., Frauscher, F., Rosenberg, M., & Gomella, L. G. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.178.4.1780915 · Cited by 81
Self-citationMitterberger, M. J., Aigner, F., Horninger, W., Ulmer, H., Cavuto, S., Halpern, E. J., & Frauscher, F. (2010) · European Radiology · doi:10.1007/s00330-010-1860-1 · Cited by 78
Self-citationThe Continuing Importance of Transrectal Ultrasound Identification of Prostatic Lesions
Toi, A., Neill, M. G., Lockwood, G. A., Sweet, J., Tammsalu, L. A., & Fleshner, N. E. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.09.061 · Cited by 74 · cited 2×
“Toi et al [36] reviewed 7426 biopsies and found that the presence of a sonographic lesion significantly increased the likelihood of cancer detection (50.”
BackgroundInfluentialLeen, E. L. S., Averkiou, M. A., Arditi, M., Burns, P. N., Bokor, D., Gauthier, T. P., Kono, Y., & Lucidarme, O. (2012) · European Radiology · doi:10.1007/s00330-011-2373-2 · Cited by 68 · cited 1×
“Microbubble-specific techniques allow imaging of vessels down to 50–100 mm in diameter [46, 47].”
MethodAngiogenesis imaging in the management of prostate cancer
Padhani, A. R., Harvey, C. J., & Cosgrove, D. O. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0356 · Cited by 66 · cited 1×
“Imaging techniques that allow quantification of blood flow in these microvessels may provide the opportunity to significantly improve prostate cancer detection and characterisation [44, 45].”
BackgroundSelf-citationThe value of an additional hypoechoic lesion‐directed biopsy core for detecting prostate cancer
Gosselaar, C., Roobol, M. J., Roemeling, S., Wolters, T., van Leenders, G. J. L. H., & Schröder, F. H. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07309.x · Cited by 56 · cited 2×
“Gosselaar et al [35] studied 1840 males in whom 532 cancers were detected, but only 3.”
BackgroundInfluentialAigner, F., Pallwein, L., Schocke, M., Andrei, L. S., Junker, D., Schäfer, G., Mikuz, G., Pedross, F., Horninger, W., Jaschke, W. R., et al. (2011) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2011.30.5.643 · Cited by 49 · cited 1×
“In a study comparing elastography with T2 weighted endorectal MRI similar sensitivity rates and negative predictive values were obtained for the detection of prostate cancer [74].”
BackgroundSelf-citationUrologic imaging for localized prostate cancer in 2007
Loch, T. (2007) · World Journal of Urology · doi:10.1007/s00345-007-0155-x · Cited by 40
Contrast specific imaging in the detection and localization of prostate cancer
Wijkstra, H., Wink, M. H., & de la Rosette, J. J. M. C. H. (2004) · World Journal of Urology · doi:10.1007/s00345-004-0419-7 · Cited by 39
Controversies in Transrectal Ultrasonography and Prostate Biopsy
Sadeghi‐Nejad, H., Simmons, M. Z., Dakwar, G. R., & Dogra, V. S. (2006) · Ultrasound Quarterly · doi:10.1097/01.ruq.0000226875.35184.15 · Cited by 31 · cited 1×
“This is best commenced a few hours before the biopsy on the day of the procedure and may be continued for 3–5 days afterwards [26].”
BackgroundThe value and limitations of contrast-enhanced ultrasound in detection of prostate cancer.
Strazdina, A., Krūmiņa, G., & Sperga, M. (2011) · PubMed · Cited by 30
Functional imaging of tissue response to bolus injection of ultrasound contrast agent
Eckersley, R. J., Cosgrove, D. O., Blomley, M. J. K., & Hashimoto, H. (2002) · Proceedings/Proceedings - IEEE Ultrasonics Symposium · doi:10.1109/ultsym.1998.765294 · Cited by 20 · cited 1×
“The indices derived can be used to construct true functional images by displaying them on a pixel-by-pixel basis as an overlay on the greyscale image (Figure 14) [49].”
Metadata
- Authors
- Harvey, C. J., Pilcher, J., Richenberg, J., Patel, U., & Frauscher, F.
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11-01
- Volume
- 85
- Issue
- special_issue_1
- Pages
- S3-S17
- ISSN
- 0007-1285 (ISSN-L)
- OpenAlex
- W2071815979
- Cited by
- 162
- References
- 38
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.